GB983132A - Improvements in or relating to chewable hematinic tablets - Google Patents

Improvements in or relating to chewable hematinic tablets

Info

Publication number
GB983132A
GB983132A GB9911/63A GB991163A GB983132A GB 983132 A GB983132 A GB 983132A GB 9911/63 A GB9911/63 A GB 9911/63A GB 991163 A GB991163 A GB 991163A GB 983132 A GB983132 A GB 983132A
Authority
GB
United Kingdom
Prior art keywords
sugar
chewable
vitamin
tablets
hematinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB9911/63A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GB983132A publication Critical patent/GB983132A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB9911/63A 1962-04-06 1963-03-13 Improvements in or relating to chewable hematinic tablets Expired GB983132A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18566462A 1962-04-06 1962-04-06

Publications (1)

Publication Number Publication Date
GB983132A true GB983132A (en) 1965-02-10

Family

ID=22681943

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9911/63A Expired GB983132A (en) 1962-04-06 1963-03-13 Improvements in or relating to chewable hematinic tablets

Country Status (4)

Country Link
US (1) US3125491A (US06824948-20041130-C00056.png)
BE (1) BE629982A (US06824948-20041130-C00056.png)
FR (1) FR3472M (US06824948-20041130-C00056.png)
GB (1) GB983132A (US06824948-20041130-C00056.png)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2081436A1 (US06824948-20041130-C00056.png) * 1970-01-15 1971-12-03 Scherer Corp R P
GB2157167A (en) * 1981-04-13 1985-10-23 Orthomolecular Inc Sublingual vitamin b12 lozenges
CN110327303A (zh) * 2019-08-15 2019-10-15 威海百合生物技术股份有限公司 一种铁维生素c片剂及其制备方法

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3476571A (en) * 1966-05-19 1969-11-04 Gen Foods Corp Artificially sweetened fruit-flavored product
US4260596A (en) * 1979-08-13 1981-04-07 Bristol-Myers Company Edible unit dosage form consisting of outer mannitol shell and inner liquid or gel center and method for manufacturing the same
EP0263132A4 (en) * 1986-04-07 1988-11-16 Clemetson Ab Charles ASCORBIC ACID COATED WITH CATECHIN AND METHOD.
US4752479A (en) * 1986-05-27 1988-06-21 Ciba-Geigy Corporaton Multi vitamin and mineral dietary supplement with controlled release bioavailable iron
US6352713B1 (en) 1999-12-01 2002-03-05 Drugtech Corporation Nutritional composition
US6488956B1 (en) * 1994-06-20 2002-12-03 Drugtech Corporation Multi-vitamin and mineral supplements for women
KR100267576B1 (ko) 1998-07-25 2000-11-01 허계성 활성성분을 분리함유한 츄잉 연질정제 및 그의 제조방법
US6663892B1 (en) 2002-08-19 2003-12-16 L. Perrigo Company Multiple portion tablet
ATE445393T1 (de) 2003-04-24 2009-10-15 Jagotec Ag Tablette mit gefärbtem kern
DK2049123T4 (en) 2006-08-03 2016-11-28 Horizon Pharma Ag LATE discharge-glucocorticoid treatment of rheumatoid ILLNESS
EP2391369A1 (en) * 2009-01-26 2011-12-07 Nitec Pharma AG Delayed-release glucocorticoid treatment of asthma
NZ582836A (en) * 2009-01-30 2011-06-30 Nitec Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
DE102011122250A1 (de) * 2011-10-24 2013-04-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Eisenhaltige Vitaminzusammensetzung

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2410110A (en) * 1943-01-14 1946-10-29 Brewer & Company Inc Method of making tablets
US2996431A (en) * 1953-12-16 1961-08-15 Barry Richard Henry Friable tablet and process for manufacturing same
US2811483A (en) * 1954-12-09 1957-10-29 Pfizer & Co C Pharmaceutical composition and process for preparing the same
US2822317A (en) * 1955-12-12 1958-02-04 Smith Kline French Lab Aqueous iron-ascorbic acid preparation
IT573230A (US06824948-20041130-C00056.png) * 1956-05-18
US2887436A (en) * 1956-05-28 1959-05-19 Pfizer & Co C Pharmaceutical compositions
US2939820A (en) * 1956-06-11 1960-06-07 Pfizer & Co C Aqueous vitamin and mineral compositions
GB851761A (en) * 1958-01-27 1960-10-19 Glaxo Lab Ltd Therapeutic compositions containing ferrous fumarate
US2985559A (en) * 1958-01-27 1961-05-23 Glaxo Lab Ltd Stabilized therapeutic ferrous fumarate aqueous suspensions
US3019169A (en) * 1958-06-23 1962-01-30 Sterling Drug Inc Salicylate dry shell coating of dry 4-aminoquinoline core, and dry-compressing tablet-making process
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2081436A1 (US06824948-20041130-C00056.png) * 1970-01-15 1971-12-03 Scherer Corp R P
GB2157167A (en) * 1981-04-13 1985-10-23 Orthomolecular Inc Sublingual vitamin b12 lozenges
CN110327303A (zh) * 2019-08-15 2019-10-15 威海百合生物技术股份有限公司 一种铁维生素c片剂及其制备方法

Also Published As

Publication number Publication date
BE629982A (US06824948-20041130-C00056.png)
FR3472M (fr) 1965-08-09
US3125491A (en) 1964-03-17

Similar Documents

Publication Publication Date Title
GB983132A (en) Improvements in or relating to chewable hematinic tablets
ES487151A1 (es) Procedimiento de preparacion de nuevas formas galenicas de administracion de medicamentos por via oral, con liberacion programada
CA2136411A1 (en) Immediate Release Tablet Cores of Insoluble Drugs Having Sustained Release Coating
EP0195643A3 (en) Compositions and method of controlling transdermal penetration of topical and systemic agents
ES8308698A1 (es) Procedimiento para preparar una composicion penetrable por la piel a base de agentes terapeuticos sistematicamente activos
ZA912793B (en) Pharmaceutical formulations
ATE19589T1 (de) Pharmazeutische dreilagen-filmpraeparate mit lang anhaltender wirkung.
EP0096286A3 (de) Hydrolyseempfindlichen Wirkstoff enthaltende, lagerstabile Tablette
GB1161439A (en) Pharmaceutical Compositions
Zsotér et al. Effect of thyroid hormones on vascular response
US3039922A (en) Method of administering tablets having decongestant and anti-histaminic activity
GB1202148A (en) Pharmaceutical compositions
EP0310126A3 (en) Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines
GB1352257A (en) Pyridyltriazoles their preparation and compositions containing them
Samniah et al. Cerebral infarction associated with oral verapamil overdose
JPS56138110A (en) Suppository containing citric acid or salt thereof
GB1302266A (US06824948-20041130-C00056.png)
GB1210968A (en) Improvements in or relating to the treatment of gastric ailments
ES264510A1 (es) Metodo para la preparaciën de preparados de hierro de elevado poder de absorciën
GB1153324A (en) Sustained Release Tablets
GB1357813A (en) Effervescent composition for the treatment of heart diseases
GB1375806A (US06824948-20041130-C00056.png)
GB791644A (en) Barbiturate pharmaceutical preparations
GB911482A (en) Pharmaceutical tablets comprising a synergistic combination including salts of ª--phenoxyethyl penicillin
Brady et al. Verapamil in stuttering.